JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome

K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

A Cuker, GM Arepally, BH Chong, DB Cines… - Blood …, 2018 - ashpublications.org
In February 2022, these guidelines were reviewed by an expert work group convened by
ASH. Review included limited searches for new evidence and discussion of the search …

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy

SM Bates, A Rajasekhar, S Middeldorp… - Blood …, 2018 - ashpublications.org
Background: Venous thromboembolism (VTE) complicates∼ 1.2 of every 1000 deliveries.
Despite these low absolute risks, pregnancy-associated VTE is a leading cause of maternal …

Aggregation-induced emission: together we shine, united we soar!

J Mei, NLC Leung, RTK Kwok, JWY Lam… - Chemical …, 2015 - ACS Publications
Light is of essential importance to the universe and humankind. Light has been, and
continues to be, one of the most fundamental and indispensable elements to life and society …

Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm

EJ Ley, CVR Brown, EE Moore, JA Sava… - Journal of trauma and …, 2020 - journals.lww.com
This is a recommended evaluation and management algorithm from the Western Trauma
Association (WTA) Algorithms Committee focused on the management of pharmacologic …

Heparin-induced thrombocytopenia

GM Arepally - Blood, The Journal of the American Society of …, 2017 - ashpublications.org
Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy
caused by antibodies to complexes of platelet factor 4 (PF4) and heparin. Pathogenic …

Heparin-induced thrombocytopenia

A Greinacher - New England Journal of Medicine, 2015 - Mass Medical Soc
Key Clinical Points Heparin-Induced Thrombocytopenia Heparin-induced thrombocytopenia
(HIT) is characterized by a decrease in the platelet count of more than 50% from the highest …

VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence …

SM Bates, IA Greer, S Middeldorp, DL Veenstra… - Chest, 2012 - Elsevier
Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …

Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical …

P Monagle, AKC Chan, NA Goldenberg, RN Ichord… - Chest, 2012 - Elsevier
Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …

Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines

DA Garcia, TP Baglin, JI Weitz, MM Samama - Chest, 2012 - Elsevier
This article describes the pharmacology of approved parenteral anticoagulants. These
include the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight …